Patents by Inventor Federico Stroppolo

Federico Stroppolo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Extended release tablet comprising a weight-loss drug
    Patent number: 11744809
    Abstract: An extended release tablet (ERT), having phentermine or a pharmaceutically acceptable salt thereof, and one or more of a wax and a pharmaceutically acceptable excipient selected from among one or more of a fatty acid, a bulking agent, a lubricant and the like is disclosed. A process for its preparation is also disclosed.
    Type: Grant
    Filed: November 7, 2017
    Date of Patent: September 5, 2023
    Assignee: ALPEX PHARMA SA
    Inventors: Federico Stroppolo, Gabriele Granata
  • ORODISPERSIBLE FORMULATION OF VARDENAFIL
    Publication number: 20210128569
    Abstract: The present invention includes an orodispersible polyalcohol-free formulation containing vardenafil or a pharmaceutically acceptable salt thereof as active ingredient, as well as filler, a buffering agent, a lubricant, a sweetener, a flavoring agent and, optionally, further pharmaceutically acceptable excipients.
    Type: Application
    Filed: October 21, 2020
    Publication date: May 6, 2021
    Applicant: Alpex Pharma S.A.
    Inventors: Federico STROPPOLO, Gabriele GRANATA
  • Granular composition for oral administration
    Patent number: 10688121
    Abstract: The present invention relates to a granular composition for oral suspension characterized by the presence of an insoluble resin and a silica gel.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: June 23, 2020
    Assignee: ALPEX PHARMA S.A.
    Inventors: Federico Stroppolo, Gabriele Granata
  • EXTENDED RELEASE TABLET COMPRISING A WEIGHT-LOSS DRUG
    Publication number: 20190254993
    Abstract: An extended release tablet (ERT), having phentermine or a pharmaceutically acceptable salt thereof, and one or more of a wax and a pharmaceutically acceptable excipient selected from among one or more of a fatty acid, a bulking agent, a lubricant and the like is disclosed. A process for its preparation is also disclosed.
    Type: Application
    Filed: November 7, 2017
    Publication date: August 22, 2019
    Applicant: ALPEX PHARMA SA
    Inventors: Federico STROPPOLO, Gabriele GRANATA
  • Solid dosage formulations of narcotic drugs having improved buccal adsorption
    Patent number: 10258693
    Abstract: Disclosed is a pharmaceutical composition in the form of a tablet suitable for dissolution in the buccal cavity, said composition comprising i) an effective amount of a narcotic active ingredient, and ii) a pharmaceutically acceptable amine having a pK of about 8 or greater, wherein the molar ratio of amine:active ingredient is at least about 5:1.
    Type: Grant
    Filed: September 4, 2013
    Date of Patent: April 16, 2019
    Assignee: ALPEX PHARMA S.A.
    Inventors: Federico Stroppolo, Shahbaz Ardalan
  • Granular composition for oral administration
    Patent number: 10245284
    Abstract: The present invention relates to a granular composition for oral suspension characterized by the presence of an insoluble resin and a silica gel.
    Type: Grant
    Filed: August 19, 2015
    Date of Patent: April 2, 2019
    Assignee: ALPEX PHARMA S.A.
    Inventors: Federico Stroppolo, Gabriele Granata
  • GRANULAR COMPOSITION FOR ORAL ADMINISTRATION
    Publication number: 20180214477
    Abstract: The present invention relates to a granular composition for oral suspension characterized by the presence of an insoluble resin and a silica gel.
    Type: Application
    Filed: July 28, 2016
    Publication date: August 2, 2018
    Inventors: Federico STROPPOLO, Gabriele GRANATA
  • Solid forms containing meloxicam with improved buccal taste and process for their preparation
    Patent number: 10016359
    Abstract: A solid dosage form of meloxicam containing an acid and sugars or polyalcohols or a mixture thereof.
    Type: Grant
    Filed: June 11, 2007
    Date of Patent: July 10, 2018
    Assignee: ALPEX PHARMA SA
    Inventors: Federico Stroppolo, Shahbaz Ardalan
  • GRANULAR COMPOSITION FOR ORAL ADMINISTRATION
    Publication number: 20170049806
    Abstract: The present invention relates to a granular composition for oral suspension characterized by the presence of an insoluble resin and a silica gel.
    Type: Application
    Filed: August 19, 2015
    Publication date: February 23, 2017
    Inventors: Federico Stroppolo, Gabriele Granata
  • Effervescent compositions containing N-acetylcysteine
    Patent number: 9561204
    Abstract: Effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine and a method of treating acetaminophen poisoning with effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine are described.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: February 7, 2017
    Assignee: ALPEX PHARMA S.A
    Inventors: Federico Stroppolo, Gabriele Granata, Shahbaz S. Ardalan
  • EFFERVESCENT COMPOSITIONS CONTAINING N-ACETYLCYSTEINE
    Publication number: 20160331710
    Abstract: Effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine and a method of treating acetaminophen poisoning with effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine are described.
    Type: Application
    Filed: July 28, 2016
    Publication date: November 17, 2016
    Inventors: Federico STROPPOLO, Gabriele GRANATA, Shahbaz S. ARDALAN
  • Solid dosage formulations containing weight-loss drugs
    Patent number: 9480661
    Abstract: An orally disintegrating tablet which can be chewed or disintegrated by contact with saliva and containing weight-loss drugs for weight control in humans, especially in children and adolescents, is disclosed.
    Type: Grant
    Filed: February 21, 2008
    Date of Patent: November 1, 2016
    Assignee: Alpex Pharma S.A.
    Inventors: Federico Stroppolo, Shahbaz Ardalan
  • Effervescent compositions containing N-acetylcysteine
    Patent number: 9427421
    Abstract: Effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine and a method of treating acetaminophen poisoning with effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine are described.
    Type: Grant
    Filed: July 15, 2015
    Date of Patent: August 30, 2016
    Assignee: ALPEX PHARMA S.A.
    Inventors: Federico Stroppolo, Gabriele Granata, Shahbaz S. Ardalan
  • EFFERVESCENT COMPOSITIONS CONTAINING N-ACETYLCYSTEINE
    Publication number: 20150313855
    Abstract: Effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine and a method of treating acetaminophen poisoning with effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine are described.
    Type: Application
    Filed: July 15, 2015
    Publication date: November 5, 2015
    Inventors: Federico STROPPOLO, Gabriele GRANATA, Shahbaz S. ARDALAN
  • EFFERVESCENT COMPOSITIONS CONTAINING N-ACETYLCYSTEINE
    Publication number: 20140234228
    Abstract: Effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine and a method of treating acetaminophen poisoning with effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine are described.
    Type: Application
    Filed: April 29, 2014
    Publication date: August 21, 2014
    Applicant: ALPEX PHARMA S.A.
    Inventors: Federico STROPPOLO, Gabriele Granata, Shahbaz S. Ardalan
  • Effervescent compositions containing N-acetylcysteine
    Patent number: 8747894
    Abstract: Effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine and a method of treating acetaminophen poisoning with effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine are described.
    Type: Grant
    Filed: May 8, 2012
    Date of Patent: June 10, 2014
    Assignee: Alpex Pharma S.A.
    Inventors: Federico Stroppolo, Gabriele Granata, Shahbaz Ardalan
  • SOLID DOSAGE FORMULATIONS OF NARCOTIC DRUGS HAVING IMPROVED BUCCAL ADSORPTION
    Publication number: 20140018392
    Abstract: Disclosed is a pharmaceutical composition in the form of a tablet suitable for dissolution in the buccal cavity, said composition comprising i) an effective amount of a narcotic active ingredient, and ii) a pharmaceutically acceptable amine having a pK of about 8 or greater, wherein the molar ratio of amine:active ingredient is at least about 5:1.
    Type: Application
    Filed: September 4, 2013
    Publication date: January 16, 2014
    Applicant: ALPEX PHARMA S.A.
    Inventors: Federico STROPPOLO, Shahbaz ARDALAN
  • EFFERVESCENT COMPOSITIONS CONTAINING N-ACETYLCYSTEINE
    Publication number: 20130302259
    Abstract: Effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine and a method of treating acetaminophen poisoning with effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine are described.
    Type: Application
    Filed: May 8, 2012
    Publication date: November 14, 2013
    Applicant: ALPEX PHARMA S.A.
    Inventors: Federico STROPPOLO, Gabriele GRANATA, SHAHBAZ ARDALAN
  • Solid dosage formulations of narcotic drugs having improved buccal adsorption
    Patent number: 8574552
    Abstract: Disclosed is a pharmaceutical composition in the form of a tablet suitable for dissolution in the buccal cavity, said composition comprising i) an effective amount of a narcotic active ingredient, and ii) a pharmaceutically acceptable amine having a pK of about 8 or greater, wherein the molar ratio of amine:active ingredient is at least about 5:1.
    Type: Grant
    Filed: July 21, 2006
    Date of Patent: November 5, 2013
    Assignee: Alpex Pharma S.A.
    Inventors: Federico Stroppolo, Shahbaz Ardalan
  • Orally disintegrating tablets with speckled appearance
    Patent number: 8440170
    Abstract: Orally disintegrating tablets containing colored granules of a water-soluble sugar which give them a speckled appearance are described. The orally disintegrating tablets with speckled appearance are readily and easy identifiable by physicians, nurses and patients.
    Type: Grant
    Filed: January 30, 2009
    Date of Patent: May 14, 2013
    Assignee: Alpex Pharma SA
    Inventors: Federico Stroppolo, Shahbaz Ardalan